Categorized | Health, Pottstown, Social

Pottstown, Other Blood Drives Planned To March 20

Posted on 25 February 2011. Tags:

Can you spare a pint?

POTTSTOWN PA – Blood collection drives will be conducted beginning next week and continuing through March 20 in Pottstown, Gilbertsville, Phoenixville, and Douglassville PA by the Miller-Keystone Blood Center. Drives are scheduled for:

  • Tuesday (March 1) from 9 a.m. to 1:45 p.m. at Manatawny Manor, 30 Old Schuylkill Road, Pottstown PA;
  • Thursday (March 3) from 9 a.m. to noon at Sealstrip, 103 Industrial Drive, Gilbertsville PA;
  • Friday (March 4) from 11 a.m. to 3 p.m. at Subway, 512 Kimberton Road, Phoenixville PA;
  • Friday (March 4) from 8 a.m. to 12:40 p.m. at National Penn Bank, 401 Creekside Drive, Pottstown PA;
  • March 7 (Monday) from 2-7 p.m. at St. James Lutheran Church, 1101 East High Street, Pottstown PA;
  • March 13 (Sunday) from 9 a.m. to 1:30 p.m. at St. Gabriel’s Church, 1188 Ben Franklin Hwy. East, Douglassville PA;
  • March 14 (Monday) from 2-7 p.m. at Coventry Church of the Brethren, 946 Keen Street, Pottstown PA; and
  • March 20 (Sunday) from 9 a.m. to 2 p.m. at Hope Church, 117 N. Monocacy Creek Road, Douglassville PA.

Appointments are required and may be made by calling the blood bank at 610-926-6060.

Photo from Clipart.com

Share

One Response to “Pottstown, Other Blood Drives Planned To March 20”

Trackbacks/Pingbacks

  1. Saturday’s Headlines In The Post | The Sanatoga Post says:
    February 26, 2011 at 6:39 am

    [...] Pottstown, Other Blood Drives Planned To March 20 Here’s your chance (eight of them, actually) to give a pint and help save a life in Pottstown, Gilbertsville, Phoenixville, and Douglassville. [...]


From Our Sponsors

RSS Health News

  • Folic acid tied to lower child cancer risks May 22, 2012
    NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds. […]
  • Many babies with development delays may go untreated May 22, 2012
    NEW YORK (Reuters Health) - About one out of every three infants who scores well below average on a test of developmental skills -- and is therefore considered at a high risk of having delays -- does not get referred to early intervention services, according to a new study. […]
  • Mom's excess pounds key in newborn weight May 22, 2012
    NEW YORK (Reuters Health) - For at least some moms-to-be, it's extra body fat -- and not blood sugar levels -- that may be key to their risk of having a big baby, a study published Tuesday suggests. […]
  • Exercise tied to lower risk of psoriasis: study May 22, 2012
    NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics buffs, may be less likely to get psoriasis than less-active women. […]
  • Takeda drug impresses in ulcerative colitis study May 22, 2012
    (Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial. […]
  • FDA staff shoots down Pfizer rare disease drug May 22, 2012
    WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. […]
  • Eli Lilly's diabetes drug meets mid-stage trial goal May 22, 2012
    (Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. […]
  • Ramadan sets Muslim athletes extra test at London Games May 22, 2012
    LONDON (Reuters)- When Malaysian cyclist Azizulhasni Awang opted to postpone his Ramadan fast until after the London Games, the decision was all about going for Olympic gold. […]
  • Bavarian Nordic says U.S. backs new Imvamune study May 22, 2012
    COPENHAGEN (Reuters) - Danish biopharma firm Bavarian Nordic said on Tuesday that the U.S. Department of Health and Human Services has supported the initiation of an expanded phase 3 study of its smallpox vaccine Imvamune. […]
  • "Pre-diabetes," diabetes rising among U.S. teens May 21, 2012
    By Amy Norton NEW YORK (Reuters Health) - The percentage of U.S. teenagers with "pre-diabetes" or full-blown type 2 diabetes has more than doubled in recent years -- though obesity and other heart risk factors have held steady, government researchers reported Monday. […]